- Guide to PHARMACOLOGY
Compound class: Synthetic organic
Comment: Compound 5 is the lead identified from a target-based approach to develop new compounds with antimalarial activity .
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Guide to Malaria Pharmacology Comments|
|Compound 5 was optimized, using a structure-based aproach, from the small molecule hit identified from a series of selective inhibitors of apicomplexan lysine--tRNA ligase (lysyl-tRNA synthetase) . Plasmodium lysine--tRNA ligase (PfKRS1) has been validated as a target for antimalarial drug development when it was shown to be the target of the natural product cladosporin .|